What you get by completing this session

  • 30 mins of CPD

    A 20 minute video lecture with presentation slides, you can stop and start anytime you like. 10 minute quiz is included.

  • Certificate of Completion

    Receive a certificate once you complete the session. Download this from your student dashboard or in your course completion email

  • Easy CPD Documentation

    Fill out the CPD Documentation activity at the end of the session, receive a PDF summary of your CPD activity and reflection right to your email inbox to save or print out!

What you'll learn in this expert session

When initiating menopausal hormone therapy (MHT) in symptomatic, menopausal patients, an important first decision that needs to be made is what dose of what formulation would be best for the particular woman.

In this presentation, Prof Rodney Baber AM will discuss the relevant, evidence-based recommendations for MHT, including appropriate mode of delivery, dosage, monitoring of effectiveness and side effects, as well as what to do when response is inadequate, which is not just a case of increasing the dose.

About the Expert

Prof Rodney Baber AM

Prof Baber AM is Professor of Obstetrics and Gynaecology at The University of Sydney. Prof Baber is a life member and Past President of both the Australasian menopause Society and the International Menopause Society. He was editor in chief of Climacteric from 2016-2024 and chair of the scientific programme committee for the 2024 World Congress on Menopause held in Melbourne. His awards include the RANZCOG Distinguished service medal, The IMS Lifetime Achievement and Distinguished Service awards and Membership of The Order of Australia for service to Obstetrics and Gynaecology.